Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism

Movement Disorders

Volumn 29, Issue 13, 2014, Pages 1684-1687

  Appel Cresswell, Silke ^a   Rajput, Ali H ^b   Sossi, Vesna ^a   Thompson, Christina ^a   Silva, Vanessa ^a   Mckenzie, Jessamyn ^a   Dinelle, Katherine ^a   Mccormick, Siobhan E ^a   Vilariño Güell, Carles ^a   Stoessl, A Jon ^a   Dickson, Dennis W ^c   Robinson, Chris A ^b   Farrer, Matthew J ^a   Rajput, Alex ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SASKATOON HEALTH REGION   (Canada)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

DNAJC13; Familial PD; Lewy Body Pathology; Mennonite; Parkinson's disease (PD); Positron Emission Tomography (PET)

Indexed keywords

CARBON; CHAPERONE; DIHYDROTETRABENAZINE; DNAJC13 PROTEIN, HUMAN; DOPAMINE RECEPTOR STIMULATING AGENT; FLUORODEOXYGLUCOSE F 18; LEVODOPA; TETRABENAZINE;

AGED; ANALOGS AND DERIVATIVES; BRAIN; DIAGNOSTIC USE; DRUG EFFECTS; FAMILY HEALTH; GENETICS; HUMAN; MIDDLE AGED; MUTATION; PARKINSONIAN DISORDERS; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN; CARBON ISOTOPES; DOPAMINE AGENTS; FAMILY HEALTH; FLUORODEOXYGLUCOSE F18; HUMANS; LEVODOPA; MIDDLE AGED; MOLECULAR CHAPERONES; MUTATION; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; TETRABENAZINE;

EID: 84911142289     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26019     Document Type: Article

References (10)

1. Racette BA, Rundle M, Wang JC, et al. A multi-incident, Old-Order Amish family with PD. Neurology 2002;58:568-574.
2. Vilarino-Guell C, Rajput A, Milnerwood AJ, et al. DNAJC13 mutations in Parkinson disease. Hum Mol Genet 2014;23:1794-1801.
3. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism-a prospective study. Can J Neurol Sci 1991;18:275-278.
4. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
5. Nandhagopal R, Kuramoto L, Schulzer M, et al. Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. Brain 2009;132:2970-2979.
6. Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A. Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 2009;73:206-212.
7. de Rijk MC, Launer LJ, Berger K, et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54(11 Suppl 5):S21-S23.
8. Klein C, Chuang R, Marras C, Lang AE. The curious case of phenocopies in families with genetic Parkinson's disease. Mov Disord 2011;26:1793-1802.
9. Rajput AH, Uitti RJ, Stern W, et al. Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson's disease. Can J Neurol Sci 1987;14(3 Suppl):414-418.
10. 11C]raclopride. Mov Disord 1997;12:33-38.